# The Standard Care vs. COrticosteroid for REtinal Vein Occlusion (SCORE) Study

> **NCT00105027** · PHASE3 · COMPLETED · sponsor: **The Emmes Company, LLC** · enrollment: 682 (actual)

## Conditions studied

- Macular Edema, Cystoid
- Retinal Vein Occlusion

## Interventions

- **OTHER:** Standard Care
- **DRUG:** intravitreal triamcinolone injection
- **DRUG:** intravitreal triamcinolone injection

## Key facts

- **NCT ID:** NCT00105027
- **Lead sponsor:** The Emmes Company, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-10
- **Primary completion:** 2009-02
- **Final completion:** 2009-02
- **Target enrollment:** 682 (ACTUAL)
- **Last updated:** 2018-07-02

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00105027

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00105027, "The Standard Care vs. COrticosteroid for REtinal Vein Occlusion (SCORE) Study". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00105027. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*